Related Experiment Video
Updated: Apr 23, 2026

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
Treatment of Valsalva retinopathy
Zhengfeng Liu1, Xuemei Pan, Hongsheng Bi
1*MD Shandong University of Traditional Chinese Medicine, Jinan, China (ZL); Affiliated Eye Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China (XP, HB); and Eye Institute of Shandong University of Traditional Chinese Medicine, Jinan, China (HB).
Purpose:
To report a case of Valsalva retinopathy treated by neodymium-doped yttrium aluminum garnet (Nd:YAG) laser and discuss the previously reported treatments for Valsalva retinopathy.
Case Report:
A 35-year-old-woman experienced a sudden painless visual loss in her left eye after lifting heavy bags of manure on the farm. The patient was diagnosed as having Valsalva retinopathy. The examination revealed a macular preretinal hemorrhage. An Nd:YAG laser was used on the patient after conservative management afforded no resolution. After treatment, visual acuity improved.
Conclusions:
Valsalva retinopathy can be treated by conservative management, Nd:YAG laser, and vitrectomy, but each treatment must be evaluated in regard to the duration, the location, and the amount of the hemorrhage.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Diabetic Retinopathy
Mitral Stenosis III: Medical Management
Mitral Regurgitation III: Medical Management
Glaucoma: Overview

